#MedTwitter
#MedTwitter
/5
#melsm #MedTwitter #OncTwitter
/5
#melsm #MedTwitter #OncTwitter
#OncTwitter @oncoalert.bsky.social
#OncTwitter @oncoalert.bsky.social
1️⃣ 4/4 #radonc in my family donated this year to #HCWvsHunger for our #oncTwitter team
2️⃣ my 🍎order arrived just in time for our last day
3️⃣ honored to run #DiagnoseAndTreats with Drs @kemimdrad.bsky.social @tmprowell.bsky.social @rovingatuscap.bsky.social
@01sth02.bsky.social 🙏
1️⃣ 4/4 #radonc in my family donated this year to #HCWvsHunger for our #oncTwitter team
2️⃣ my 🍎order arrived just in time for our last day
3️⃣ honored to run #DiagnoseAndTreats with Drs @kemimdrad.bsky.social @tmprowell.bsky.social @rovingatuscap.bsky.social
@01sth02.bsky.social 🙏
🧠And while we finalize the case details, collect FREE #CME
👉🏽http://integrityce.com/TBT2024 #OncTwitter
🧠And while we finalize the case details, collect FREE #CME
👉🏽http://integrityce.com/TBT2024 #OncTwitter
COMET trial published concurrently @jama.com:
ja.ma/3Zx8hiL
With accompanying editorial (see 📸): jamanetwork.com/journals/jam...
@oncoalert.bsky.social
/3
COMET trial published concurrently @jama.com:
ja.ma/3Zx8hiL
With accompanying editorial (see 📸): jamanetwork.com/journals/jam...
@oncoalert.bsky.social
/3
Apply by March 12th: https://bit.ly/4rhR8pn
#OncTwitter #ResearchFunding
Apply by March 12th: https://bit.ly/4rhR8pn
#OncTwitter #ResearchFunding
⭐️Case 1⭐️
55 yo 👩 never 🚬 p/w hemoptysis
CT shows 6x6x9 cm LLL mass 🫁
Bronchoscopy➡️ lung adeno, N2+
EGFR L878R on mol testing🧬
⭐️Case 1⭐️
55 yo 👩 never 🚬 p/w hemoptysis
CT shows 6x6x9 cm LLL mass 🫁
Bronchoscopy➡️ lung adeno, N2+
EGFR L878R on mol testing🧬
Read his latest in @JAMANetworkOpen!
#MedEd #HealthEquity #OncTwitter
Read his latest in @JAMANetworkOpen!
#MedEd #HealthEquity #OncTwitter
A big thank you to everyone who visited the ONCOassist Booth 10095 and connected with us throughout the day 🤝
Looking forward to seeing everyone on Day 4!
#OncoNews #OncoAlert #OncTwitter #OncEd #Chicago
A big thank you to everyone who visited the ONCOassist Booth 10095 and connected with us throughout the day 🤝
Looking forward to seeing everyone on Day 4!
#OncoNews #OncoAlert #OncTwitter #OncEd #Chicago
In contrast, if a replacement trial shows superiority, a smaller PFS benefit may be meaningful, especially if there is another advantage such as more favorable toxicity profile, greater patient convenience, etc.
@oncoalert.bsky.social
HOWEVER…
In contrast, if a replacement trial shows superiority, a smaller PFS benefit may be meaningful, especially if there is another advantage such as more favorable toxicity profile, greater patient convenience, etc.
@oncoalert.bsky.social
HOWEVER…
"Resharing this thread about how to recognize #melanoma because it’s summer. Several states have free #skincancer screenings going on now. See full thread for link to check if your state..."
PSA from Dec 2024:
threadreaderapp.com/thread/18734...
"Resharing this thread about how to recognize #melanoma because it’s summer. Several states have free #skincancer screenings going on now. See full thread for link to check if your state..."
PSA from Dec 2024:
threadreaderapp.com/thread/18734...
View the abstracts: brnw.ch/21wYQVs
View the abstracts: brnw.ch/21wYQVs
Read the review: https://bit.ly/3QkAJTS
#BCSM #MedEd #OncTwitter #ClinicalTrials
Read the review: https://bit.ly/3QkAJTS
#BCSM #MedEd #OncTwitter #ClinicalTrials
Ongoing trials could expand the reach of precision therapy beyond mCRPC
#ProstateCancer #Oncology #OncTwitter #MedEd #MedX #mPC #mHSPC
Ongoing trials could expand the reach of precision therapy beyond mCRPC
#ProstateCancer #Oncology #OncTwitter #MedEd #MedX #mPC #mHSPC